MetaVia Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States · Nasdaq: MTVA
MetaVia Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2014. Its shares trade on Nasdaq under the ticker MTVA. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2025.
MetaVia at a glance
What does MetaVia do?
Private fundraising reported to the SEC
13 Form D notices; the most recent reported $10 million sold (2025).
Frequently asked questions about MetaVia
Where is MetaVia headquartered?
MetaVia Inc. is headquartered in Cambridge, Massachusetts, United States.
What does MetaVia do?
MetaVia Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is MetaVia a public company?
Yes. MetaVia Inc. trades on Nasdaq under the ticker MTVA.
When was MetaVia founded?
The earliest incorporation on record for MetaVia Inc. is in 2014, according to public company registers.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences